Covered recipient · General Payments record
KASEE A WIESEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$2,437.81
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.61 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.97 | 8 |
| Amgen Inc. | $58.18 | 4 |
| PFIZER INC. | $57.32 | 4 |
| Otsuka America Pharmaceutical, Inc. | $43.04 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $30.40 | 1 |
| Acerta Pharma LLC | $28.79 | 2 |
| Lundbeck LLC | $20.01 | 1 |
| Ardelyx, Inc. | $16.89 | 1 |
| Lilly USA, LLC | $14.04 | 1 |
| Novo Nordisk AS | $13.57 | 1 |
| Vanda Pharmaceuticals Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.53 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409508 | CMS |
| ABBVIE INC. | $18.03 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409510 | CMS |
| ABBVIE INC. | $16.90 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409512 | CMS |
| ABBVIE INC. | $13.94 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409514 | CMS |
| ABBVIE INC. | $18.16 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409516 | CMS |
| ABBVIE INC. | $32.32 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409518 | CMS |
| ABBVIE INC. | $14.30 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409520 | CMS |
| ABBVIE INC. | $14.79 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409522 | CMS |
| Amgen Inc. | $14.22 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414969 | CMS |
| Amgen Inc. | $13.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717766 | CMS |
| Amgen Inc. | $15.22 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414971 | CMS |
| Amgen Inc. | $15.22 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414973 | CMS |
| Ardelyx, Inc. | $16.89 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146750228 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.79 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104690336 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104468586 | CMS |
| Boston Scientific Corporation | $30.40 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092580329 | CMS |
| Lilly USA, LLC | $14.04 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135733532 | CMS |
| Lundbeck LLC | $20.01 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146106827 | CMS |
| Novo Nordisk Inc | $13.57 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100448751 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.71 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119213509 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.76 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119213511 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.57 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119213513 | CMS |
| PFIZER INC. | $14.75 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001475 | CMS |
| PFIZER INC. | $13.18 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131061848 | CMS |
| PFIZER INC. | $14.72 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131425340 | CMS |
| PFIZER INC. | $14.67 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132123617 | CMS |
| Vanda Pharmaceuticals Inc. | $13.40 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133976456 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.